Learn more

ATHENA NEUROSCIENCES INC

Overview
  • Total Patents
    163
About

ATHENA NEUROSCIENCES INC has a total of 163 patent applications. Its first patent ever was published in 1990. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are PROCYON BIOPHARMA INC, ICOS CORP BOTHELL and OSCIENT PHARMACEUTICALS CORP.

Patent filings per year

Chart showing ATHENA NEUROSCIENCES INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Thorsett Eugene D 61
#2 Pleiss Michael A 41
#3 Latimer Lee H 35
#4 Nissen Jeffrey S 35
#5 John Varghese 29
#6 Seubert Peter A 28
#7 Audia James E 26
#8 Porter Warren J 25
#9 Wu Jing 24
#10 Schenk Dale B 22

Latest patents

Publication Filing date Title
US6683075B1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use
US6642261B2 N-(aryl/heteroarylacety) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
ZA9810932B Prevention of and treatment of amyloidogenic disease.
US6559127B1 Compounds which inhibit leukocyte adhesion mediated by VLA-4
US6423688B1 Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4
US6362341B1 Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4
US6492421B1 Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
ZA9806830B Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4.
US6291453B1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
US6506782B1 Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6635632B1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6117901A N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for use
US6096782A N-(aryl/heteroaryl) amino acid derivatives pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US5965614A N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
AU1684097A Beta-secretase isolated from human 293 cells
US5792799A Parenteral delivery of MAO A inhibitors
AU6168396A Method for identifying alzheimer's disease therapeutics usin g transgenic animal models
AU6383396A Beta-secretase, antibodies to beta-secretase, and assays for detecting beta-secretase inhibition
AU6264996A Method for identifying alzheimer's disease therapeutics usin g transgenic animal models
WO9640982A1 Therapeutic inhibition of phospholipase a2 in neurodegenerative disease